AstraZeneca Gives Rejected Drugs a Second Life

AstraZeneca is working with outside researchers to look for untapped potential in drugs that the company has shelved, part of a broader move to improve its research-and-development output.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: FREE Source Type: news